Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 69 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9132107

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Jazz Pharmaceuticals Ireland Limited · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  2. US 9132174

    Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

    Anchored RSK3 Inhibitors, LLC · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  3. US 9132138

    Method for the treatment of multiple sclerosis

    CASI Pharmaceuticals, Inc · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  4. US 9127277

    Methods and compositions for prevention or treatment of RSV infection

    Alnylam Pharmaceuticals, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  5. US 9126941

    Treatment of hyperproliferative disorders with diarylhydantoin compounds

    The Regents of the University of California · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  6. US 9121852

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  7. US 9119863

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  8. US 9119884

    LLP2A-bisphosphonate conjugates for osteoporosis treatment

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  9. US 9120813

    Oxadiazoanthracene compounds for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  10. US 9115120

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  11. US 9115371

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  12. US 9114102

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  13. US 9110064

    Methods for diagnosis and treatment of endometrial cancer

    The Regents of the University of California · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  14. US 9107912

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  15. US 9107887

    Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

    Provectus Pharmaceuticals, Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  16. US 9102626

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  17. US 9095579

    Protection and treatment against influenza infection

    The Regents of the University of California · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  18. US 9096499

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  19. US 9089698

    Method and apparatus for optogenetic treatment of blindness including retinitis pigmentosa

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  20. US 9089531

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  21. US 9080174

    HBV treatment

    Benitec Biopharma Limited · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  22. US 9072732

    Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease

    The Regents of the University of California · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  23. US 9068007

    Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  24. US 9068002

    Treatment of multiple sclerosis and/or rheumatoid arthritis

    Universität Regensburg · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.